Tourette Syndrome

Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics.

What is Tourette Syndrome?

Tourette syndrome is a neurological condition affecting the brain and nervous system. It is typically characterized by involuntary movements and noises known of as tics. The disease was named after a French physician called Georges Gilles de la Tourette who first described the condition in the 19th century.

Tourette Syndrome Classification

Tourette Syndrome Prognosis

Definition and DSM-5: Classification: Tic Disorders

Living with Tourette Syndrome

Latest Tourette Syndrome News and Research

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Researchers compared the shared genetic risk and biological foundations of neurological and mental illnesses.

1 Aug 2023

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found lucrative so-called "orphan" drugs earn manufacturing tax credits, have longer patent exclusivities and face easier Food and Drug Administration review.

12 Jun 2023

No increased risk of neuropsychiatric events in children born to mothers using leukotriene-receptor antagonists in pregnancy

A new study examined the associations between leukotriene-receptor antagonists (LTRAs) use in pregnancy and neuropsychiatric events (NEs) risk in the offspring.

13 Mar 2023

New wrist device reduces the severity and frequency of tics experienced by individuals with Tourette’s

The results of the clinical trial of a new wrist device designed to help control the symptoms of Tourette syndrome have shown it significantly reduces the severity and frequency of tics.

13 Mar 2023

Removal of cilia from the brain's striatum impairs time perception and judgment, study finds

Researchers at the University of California, Irvine have discovered that removal of cilia from the brain's striatum region impaired time perception and judgment, revealing possible new therapeutic targets for mental and neurological conditions including schizophrenia, Parkinson's and Huntington's diseases, autism spectrum disorder, and Tourette syndrome.

30 Nov 2022

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Anxiety, autism, schizophrenia and Tourette syndrome each have their own distinguishing characteristics, but one factor bridging these and most other mental disorders is circadian rhythm disruption, according to a team of neuroscience, pharmaceutical sciences and computer science researchers at the University of California, Irvine.

2 Sep 2022

Repurposing an antipsychotic drug to treat various types of cancer

To treat some of the psychosis issues associated with Parkinson's disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions.

28 Jul 2022

$Tics associated with Tourette syndrome have a fractal pattern, research shows$

Tics associated with Tourette syndrome have a fractal pattern, research shows

During the pandemic, news reports surfaced of a surge of young adults showing up at doctors' offices with unexplainable movement disorders that looked, perhaps to a nonspecialist, a little bit like Tourette syndrome.

23 Feb 2022

Study assesses the impact of tic suppression on brain functional connectivity in Tourette syndrome

Tourette syndrome, a neurodevelopmental disorder, causes motor and phonic "tics" or uncontrollable repeated behaviors and vocalizations. People affected by Tourette syndrome can often suppress these tics for some time before the urges become overwhelming, and researchers have long wondered at the neural underpinnings of the suppression effort.

7 Jul 2021

RDM Positive Impact Foundation funds $1.25 million research project to study SYNGAP1

The RDM Positive Impact Foundation is funding an ambitious $1.25 million research project at the UC Davis MIND Institute to study SYNGAP1.

22 Jun 2021

Neurodiverse employees within organizations can promote skill base

At the start of Neurodiversity Celebration Week, new research from Cranfield University demonstrates the importance of organizations becoming more inclusive employers when it comes to neurodiversity.

22 Mar 2021

Study reveals specific neuronal circuits underlying environment-based value learning

How valuable are earmuffs? The answer to this simple question can depend. What brand are they? Are they good quality? What is the weather like? Given the choice between earmuffs and suntan lotion, most people would choose to have the earmuffs on a cold winter day and the lotion on a sunny day at the beach.

22 Jan 2021

Study shows high prevalence of mental health conditions among children with autism

Nearly 78 per cent of children with autism have at least one mental health condition and nearly half have two mental health conditions or more, according to a new U.S. study from the University of British Columbia's department of psychology and the AJ Drexel Autism Institute at Drexel University (Pennsylvania).

19 Jan 2021

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients.

15 Dec 2020

Tourette Syndrome

Overview

Tourette Syndrome Classification

Tourette Syndrome Prognosis

Definition and DSM-5: Classification: Tic Disorders

Feature Articles

Living with Tourette Syndrome

Latest Tourette Syndrome News and Research

Research reveals surprising genetic overlap between neurological and psychiatric disorders

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

No increased risk of neuropsychiatric events in children born to mothers using leukotriene-receptor antagonists in pregnancy

New wrist device reduces the severity and frequency of tics experienced by individuals with Tourette’s

Removal of cilia from the brain's striatum impairs time perception and judgment, study finds

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Repurposing an antipsychotic drug to treat various types of cancer

Tics associated with Tourette syndrome have a fractal pattern, research shows

Study assesses the impact of tic suppression on brain functional connectivity in Tourette syndrome

RDM Positive Impact Foundation funds $1.25 million research project to study SYNGAP1

Neurodiverse employees within organizations can promote skill base

Study reveals specific neuronal circuits underlying environment-based value learning

Study shows high prevalence of mental health conditions among children with autism

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

Cannabidiol may reduce behavioral problems in children with intellectual disabilities

Yale researchers discover the cause for sudden onset of OCD in children

Using functional MRI to demonstrate neural suppression in autism

Neuroscientists investigate how the brain controls the voice

Scientists shed new light on neuronal circuits that acquire and update voluntary actions

Researchers find many psychiatric disorders share the same gene variants

Breaking Barriers: ANDYSMANCLUB's Fight for Men's Mental Health on World Mental Health Day

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Tourette Syndrome

Overview

Feature Articles

Living with Tourette Syndrome

Latest Tourette Syndrome News and Research

Breaking Barriers: ANDYSMANCLUB's Fight for Men's Mental Health on World Mental Health Day

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Newsletters you may be interested in